Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A

por Velázquez-Moctezuma, Rodrigo, Law, Mansun, Bukh, Jens, Prentoe, Jannick
Publicado 2017

HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice

por Prentoe, Jannick, Verhoye, Lieven, Velázquez Moctezuma, Rodrigo, Buysschaert, Caroline, Farhoudi, Ali, Wang, Richard, Alter, Harvey, Meuleman, Philip, Bukh, Jens
Publicado 2016

Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies

por Velázquez-Moctezuma, Rodrigo, Augestad, Elias H., Castelli, Matteo, Holmboe Olesen, Christina, Clementi, Nicola, Clementi, Massimo, Mancini, Nicasio, Prentoe, Jannick
Publicado 2021

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization

por Pham, Long V., Velázquez-Moctezuma, Rodrigo, Fahnøe, Ulrik, Collignon, Laura, Bajpai, Priyanka, Sølund, Christina, Weis, Nina, Holmbeck, Kenn, Prentoe, Jannick, Bukh, Jens
Publicado 2022

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

por Prentoe, Jannick, Janitzek, Christoph M., Velázquez-Moctezuma, Rodrigo, Soerensen, Andreas, Jørgensen, Thomas, Clemmensen, Stine, Soroka, Vladislav, Thrane, Susan, Theander, Thor, Nielsen, Morten A., Salanti, Ali, Bukh, Jens, Sander, Adam F.
Publicado 2022

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens

por Prentoe, Jannick, Janitzek, Christoph M., Velázquez-Moctezuma, Rodrigo, Goksøyr, Louise, Olsen, Rebecca W., Fanalista, Margherita, Augestad, Elias H., Thrane, Susan, Pihl, Anne F., Gottwein, Judith M., Sander, Adam F., Bukh, Jens
Publicado 2021

Identification of novel neutralizing determinants for protection against HCV

por Alzua, Garazi P., Pihl, Anne F., Offersgaard, Anna, Velázquez‐Moctezuma, Rodrigo, Duarte Hernandez, Carlos R., Augestad, Elias H., Fahnøe, Ulrik, Mathiesen, Christian K., Krarup, Henrik, Law, Mansun, Prentoe, Jannick, Bukh, Jens, Gottwein, Judith M.
Publicado 2023

An alternate conformation of HCV E2 neutralizing face as an additional vaccine target

por Tzarum, Netanel, Giang, Erick, Kadam, Rameshwar U., Chen, Fang, Nagy, Kenna, Augestad, Elias H., Velázquez-Moctezuma, Rodrigo, Keck, Zhen-Yong, Hua, Yuanzi, Stanfield, Robyn L., Dreux, Marlene, Prentoe, Jannick, Foung, Steven K. H., Bukh, Jens, Wilson, Ian A., Law, Mansun
Publicado 2020

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

por Keck, Zhen-Yong, Pierce, Brian G., Lau, Patrick, Lu, Janine, Wang, Yong, Underwood, Alexander, Bull, Rowena A., Prentoe, Jannick, Velázquez-Moctezuma, Rodrigo, Walker, Melanie R., Luciani, Fabio, Guest, Johnathan D., Fauvelle, Catherine, Baumert, Thomas F., Bukh, Jens, Lloyd, Andrew R., Foung, Steven K. H.
Publicado 2019